Report of the joint leprosy-tuberculosis project in Paraguay.
D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D007917:Leprostatic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy*; D010239:Paraguay; D011515:Prothionamide / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*
D004338:Drug Combinations; D007917:Leprostatic Agents; C011004:isoprodian; D011515:Prothionamide; D003622:Dapsone; D007538:Isoniazid; D012293:Rifampin